Application Note: Robust and reproducible neurofilament light quantitation in serum and plasma samples using Ella
20 November 2020

Neurofilament light (NF-L) has emerged as a biomarker for diagnosing and monitoring the progression of a variety of neuropathies such as Huntington’s disease, amyotrophic lateral sclerosis (ALS), Alzheimer’s disease, and multiple sclerosis. The Simple Plex NF-L Assay on Ella delivers the sensitivity required to measure NF-L with a high level of reproducibility in serum, plasma and CSF sample types. This application note  demonstrates the Simple Plex NF-L Assay’s ability to distinguish between normal and disease state samples.